idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Grafik: idw-Logo

idw - Informationsdienst
Wissenschaft

Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instance:
Share on: 
02/14/2025 09:56

Reduced prediabetes in people who ate broccoli compound

Press contact: Margareta G. Kubista, tel. +46 705 30 19 80, email press@sahlgrenska.gu.se Communications Department
Schwedischer Forschungsrat - The Swedish Research Council

    The chemical compound sulforaphane found in broccoli sprouts can be linked to improved blood sugar levels in prediabetes, a precursor to type 2 diabetes. This has been shown in a study conducted at the University of Gothenburg. The broccoli compound had a more significant effect on blood sugar levels in certain people.

    Researchers at the University of Gothenburg have previously identified sulforaphane as an antidiabetic agent in type 2 diabetes. A patient study conducted in 2017 demonstrated significantly lower blood sugar in people with diabetes after they took large doses of sulforaphane extracted from broccoli sprouts.

    In this new study, published in Nature Microbiology, Professor Anders Rosengren and colleagues have instead looked at prediabetes. This condition is a precursor to type 2 diabetes, with slowly rising blood sugar levels due to impaired insulin production.

    The study encompassed 89 people with elevated fasting blood sugar, an indicator of prediabetes. Other criteria included the participants being overweight or obese and 35–75 years old.

    The participants were randomly assigned sulforaphane or a placebo for twelve weeks. Neither the participants nor the researchers knew who was assigned which. A total of 74 participants completed all stages of the study.

    Fasting blood sugar fell

    The results show that participants taking the sulforaphane compound had a higher average reduction in fasting blood sugar than those taking the placebo. The difference between the two groups in the study was considerable.

    An even greater difference was seen when analyzing clinical subgroups. The group with the greatest improvement after taking sulforaphane had early signs of mild age-related diabetes, a relatively low BMI in the context of the study, low insulin resistance, low incidence of fatty liver disease, and low insulin secretion.

    The third stage, conducted in collaboration with Professor Fredrik Bäckhed at the University of Gothenburg, involved the study of gut bacteria, with the discovery of a gut bacterium able to interact with sulforaphane that could be linked to further improved efficacy of the broccoli compound.

    In terms of numbers, the differences in fasting blood sugar were 0.2 millimoles per liter between all participants taking sulforaphane compared to the placebo group, followed by 0.4 in the concerned clinical subgroup, and 0.7 in those who were both in the clinical subgroup and had the gut bacterium.

    Possible precision treatment

    The prevalence of prediabetes in Sweden is estimated to be up to ten percent, with no clear treatment structure currently in place. While the condition often remains undetected, early detection increases the chances of not developing type 2 diabetes. Anders Rosengren emphasizes the importance of early and individualized interventions to prevent the disease.

    "The treatment of prediabetes is currently lacking in many respects, but these new findings open the way for possible precision treatment using sulforaphane extracted from broccoli as a functional food. However, lifestyle factors remain the foundation of any treatment for prediabetes, including exercise, healthy eating, and weight loss," he says.

    "The results of the study also offer a general model of how pathophysiology and gut flora interact with and influence treatment responses. A model that could have broader implications," Anders Rosengren ends.


    Contact for scientific information:

    Anders Rosengren, Professor of Molecular Medicine at Sahlgrenska Academy, University of Gothenburg, tel. +46 705 31 67 04, anders.rosengren@gu.se


    Original publication:

    Sulforaphane reduces fasting blood glucose in a randomized trial in prediabetes with differential effect based on pathophysiology and microbiome composition, https://doi.org/10.1038/s41564-025-01932-w


    Images

    Anders Rosengren
    Anders Rosengren
    photo: Johan Wingborg


    Criteria of this press release:
    Journalists
    Medicine
    transregional, national
    Research results
    English


     

    Help

    Search / advanced search of the idw archives
    Combination of search terms

    You can combine search terms with and, or and/or not, e.g. Philo not logy.

    Brackets

    You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).

    Phrases

    Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.

    Selection criteria

    You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).

    If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).